Investigate the Efficacy and Safety of Farudodstat Compared With Its Placebo in Adult Alopecia Areata Participants
Condition: Alopecia Areata Interventions: Drug: Farudodstat; Drug: Placebo Sponsor: ASLAN Pharmaceuticals Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 18, 2023 Category: Research Source Type: clinical trials
Phase I Study of Safety and Pharmacokinetics of Topical Solution in Subjects With Androgenetic Alopecia
Condition: Androgenetic Alopecia Intervention: Drug: Minoxidil Sponsors: Aneira Pharma, Inc.; DataPharm Australia, CMAX Clinical Research, Agilex Australia Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 18, 2023 Category: Research Source Type: clinical trials
Investigate the Efficacy and Safety of Farudodstat Compared With Its Placebo in Adult Alopecia Areata Participants
Condition: Alopecia Areata Interventions: Drug: Farudodstat; Drug: Placebo Sponsor: ASLAN Pharmaceuticals Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 18, 2023 Category: Research Source Type: clinical trials
Phase I Study of Safety and Pharmacokinetics of Topical Solution in Subjects With Androgenetic Alopecia
Condition: Androgenetic Alopecia Intervention: Drug: Minoxidil Sponsors: Aneira Pharma, Inc.; DataPharm Australia, CMAX Clinical Research, Agilex Australia Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 18, 2023 Category: Research Source Type: clinical trials
Investigate the Efficacy and Safety of Farudodstat Compared With Its Placebo in Adult Alopecia Areata Participants
Condition: Alopecia Areata Interventions: Drug: Farudodstat; Drug: Placebo Sponsor: ASLAN Pharmaceuticals Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 18, 2023 Category: Research Source Type: clinical trials
Phase I Study of Safety and Pharmacokinetics of Topical Solution in Subjects With Androgenetic Alopecia
Condition: Androgenetic Alopecia Intervention: Drug: Minoxidil Sponsors: Aneira Pharma, Inc.; DataPharm Australia, CMAX Clinical Research, Agilex Australia Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 18, 2023 Category: Research Source Type: clinical trials
Investigate the Efficacy and Safety of Farudodstat Compared With Its Placebo in Adult Alopecia Areata Participants
Condition: Alopecia Areata Interventions: Drug: Farudodstat; Drug: Placebo Sponsor: ASLAN Pharmaceuticals Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 18, 2023 Category: Research Source Type: clinical trials
Phase I Study of Safety and Pharmacokinetics of Topical Solution in Subjects With Androgenetic Alopecia
Condition: Androgenetic Alopecia Intervention: Drug: Minoxidil Sponsors: Aneira Pharma, Inc.; DataPharm Australia, CMAX Clinical Research, Agilex Australia Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 18, 2023 Category: Research Source Type: clinical trials
Investigate the Efficacy and Safety of Farudodstat Compared With Its Placebo in Adult Alopecia Areata Participants
Condition: Alopecia Areata Interventions: Drug: Farudodstat; Drug: Placebo Sponsor: ASLAN Pharmaceuticals Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 18, 2023 Category: Research Source Type: clinical trials
Phase I Study of Safety and Pharmacokinetics of Topical Solution in Subjects With Androgenetic Alopecia
Condition: Androgenetic Alopecia Intervention: Drug: Minoxidil Sponsors: Aneira Pharma, Inc.; DataPharm Australia, CMAX Clinical Research, Agilex Australia Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 18, 2023 Category: Research Source Type: clinical trials
Investigate the Efficacy and Safety of Farudodstat Compared With Its Placebo in Adult Alopecia Areata Participants
Condition: Alopecia Areata Interventions: Drug: Farudodstat; Drug: Placebo Sponsor: ASLAN Pharmaceuticals Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 18, 2023 Category: Research Source Type: clinical trials
Phase I Study of Safety and Pharmacokinetics of Topical Solution in Subjects With Androgenetic Alopecia
Condition: Androgenetic Alopecia Intervention: Drug: Minoxidil Sponsors: Aneira Pharma, Inc.; DataPharm Australia, CMAX Clinical Research, Agilex Australia Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 18, 2023 Category: Research Source Type: clinical trials